[红细胞滤过性及己酮可可碱治疗]
[Erythrocyte filterability and treatment with pentoxifylline].
作者信息
Valentini M, Sciannameo F, Francucci M, Tockner M, Sassano L, Allegra A
出版信息
Ric Clin Lab. 1983;13 Suppl 3:455-8.
The purpose of our study was to verify the possibility of obtaining a reduction in the erythrocyte filtration rate and an improvement in the O2 tissue uptake in twenty patients suffering from insulin-dependent diabetes mellitus and diabetic angiopathy, randomly divided in two groups receiving pentoxifylline (1,200 mg/day for 30 days) or a placebo solution, respectively. The erythrocyte filtration rate decreased in patients treated with pentoxifylline and the difference of erythrocyte filtration rate between the two groups was statistically significant.
我们研究的目的是验证在20名患有胰岛素依赖型糖尿病和糖尿病性血管病变的患者中，降低红细胞滤过率以及改善组织对氧的摄取的可能性。这些患者被随机分为两组，分别接受己酮可可碱（1200毫克/天，共30天）或安慰剂溶液治疗。接受己酮可可碱治疗的患者红细胞滤过率降低，两组之间红细胞滤过率的差异具有统计学意义。
Zotero 插件